Submitted by Anonymous (not verified) on 8 November 2023 - 7:30
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Constipation, Date of authorisation: 18/02/2019, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Constipation, Date of authorisation: 18/02/2019, Revision: 10, Status: Authorised